Leap Therapeutics Correlations

LPTX Stock

USD 2.58 0.01 0.39%

The current 90-days correlation between Leap Therapeutics and X4 Pharmaceuticals is 0.08 (i.e., Significant diversification). The correlation of Leap Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Leap Therapeutics Correlation With Market

Average diversification

The correlation between Leap Therapeutics and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Moving against Leap Stock

0.5	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.49	MTEM	Molecular Templates	Pair Corr
0.39	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.39	TPST	Tempest Therapeutics	Pair Corr
0.36	ME	23Andme Holding	Pair Corr
0.36	IPSC	Century Therapeutics	Pair Corr
0.32	AGL	agilon health	Pair Corr
0.48	PG	Procter Gamble	Pair Corr
0.46	KO	Coca Cola Aggressive Push	Pair Corr
0.45	EC	Ecopetrol SA ADR	Pair Corr
0.43	WF	Woori Financial Group	Pair Corr
0.43	HYMTF	Hyundai Motor	Pair Corr
0.4	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.39	SHG	Shinhan Financial	Pair Corr
0.39	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.32	TLK	Telkom Indonesia Tbk	Pair Corr

Related Correlations Analysis

	XFOR	TERN	DAWN	PDSB	INZY	EFTR	ELEV	MREO	HEPA	HOOK
XFOR		0.74	0.02	0.5	0.73	0.48	0.52	0.6	0.42	0.87	XFOR
TERN	0.74		-0.07	0.38	0.72	0.16	0.06	0.42	0.14	0.66	TERN
DAWN	0.02	-0.07		0.19	-0.08	-0.12	-0.02	0.2	-0.2	-0.1	DAWN
PDSB	0.5	0.38	0.19		0.63	0.26	-0.01	0.56	-0.15	0.4	PDSB
INZY	0.73	0.72	-0.08	0.63		0.28	0.2	0.74	0.28	0.8	INZY
EFTR	0.48	0.16	-0.12	0.26	0.28		0.59	0.38	0.39	0.45	EFTR
ELEV	0.52	0.06	-0.02	-0.01	0.2	0.59		0.49	0.75	0.62	ELEV
MREO	0.6	0.42	0.2	0.56	0.74	0.38	0.49		0.42	0.76	MREO
HEPA	0.42	0.14	-0.2	-0.15	0.28	0.39	0.75	0.42		0.63	HEPA
HOOK	0.87	0.66	-0.1	0.4	0.8	0.45	0.62	0.76	0.63		HOOK
	XFOR	TERN	DAWN	PDSB	INZY	EFTR	ELEV	MREO	HEPA	HOOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HOOK	+ 0.87	XFOR
HOOK	+ 0.8	INZY
HOOK	+ 0.76	MREO
HEPA	+ 0.75	ELEV
TERN	+ 0.74	XFOR
MREO	+ 0.74	INZY

High negative correlations

HEPA	- 0.2	DAWN
HEPA	- 0.15	PDSB
EFTR	- 0.12	DAWN
HOOK	- 0.1	DAWN
INZY	- 0.08	DAWN
DAWN	- 0.07	TERN

Risk-Adjusted Indicators

There is a big difference between Leap Stock performing well and Leap Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Leap Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
XFOR	4.87	(0.74)	(0.34)	6.90	(10.61)	62.35
TERN	3.35	(0.50)	(0.32)	5.68	(5.96)	34.09
DAWN	2.12	(0.16)	(0.08)	3.84	(3.69)	11.44
PDSB	3.33	(0.77)	(0.31)	7.67	(6.76)	31.83
INZY	2.67	(1.11)	(0.48)	5.68	(7.92)	16.62
EFTR	7.57	(4.70)	(3.44)	8.70	(27.78)	88.91
ELEV	3.50	(0.55)	(0.16)	5.77	(8.22)	22.21
MREO	2.64	(0.41)	(0.16)	5.14	(5.79)	19.32
HEPA	3.81	(0.20)	(0.05)	8.06	(8.11)	33.54
HOOK	2.74	(1.25)	(0.97)	4.05	(7.24)	15.72

Leap Therapeutics Corporate Management

Augustine Lawlor	Chief Officer	Profile
Cynthia MD	Chief Officer	Profile
Christine Granfield	VP Quality	Profile
Mark OMahony	Chief Officer	Profile
Jason Baum	Chief Officer	Profile
Cynthia Sirard	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC